Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes …
K Kotani, J Tashiro, K Yamazaki, Y Nakamura… - Clinica chimica acta, 2015 - Elsevier
Background Although increased circulating levels of malondialdehyde-modified low-density
lipoprotein (MDA-LDL) are associated with coronary artery disease (CAD), there is no direct …
lipoprotein (MDA-LDL) are associated with coronary artery disease (CAD), there is no direct …
Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes …
K Kotani, J Tashiro, K Yamazaki, Y Nakamura… - Clinica Chimica …, 2015 - infona.pl
Although increased circulating levels of malondialdehyde-modified low-density lipoprotein
(MDA-LDL) are associated with coronary artery disease (CAD), there is no direct evidence …
(MDA-LDL) are associated with coronary artery disease (CAD), there is no direct evidence …
Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes …
K Kotani, J Tashiro, K Yamazaki… - … journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Although increased circulating levels of malondialdehyde-modified low-density
lipoprotein (MDA-LDL) are associated with coronary artery disease (CAD), there is no direct …
lipoprotein (MDA-LDL) are associated with coronary artery disease (CAD), there is no direct …
Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes …
K Kotani, J Tashiro, K Yamazaki… - Clinica Chimica Acta; …, 2015 - europepmc.org
Background Although increased circulating levels of malondialdehyde-modified low-density
lipoprotein (MDA-LDL) are associated with coronary artery disease (CAD), there is no direct …
lipoprotein (MDA-LDL) are associated with coronary artery disease (CAD), there is no direct …
[引用][C] Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 …
K Kotani, J Tashiro, K Yamazaki, Y Nakamura… - Clinica Chimica …, 2015 - cir.nii.ac.jp
Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic
marker for coronary artery disease in patients with type 2 diabetes mellitus | CiNii Research …
marker for coronary artery disease in patients with type 2 diabetes mellitus | CiNii Research …